导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -22.47% | 1016/1050 |
| 近一周 | -4.71% | 1047/1104 |
| 近一月 | -13.33% | 1095/1102 |
| 近一季 | -25.06% | 1052/1092 |
| 近半年 | -28.45% | 1053/1070 |
| 近一年 | -9.22% | 734/1018 |
| 近两年 | 80.88% | 279/926 |
| 近三年 | 19.70% | 495/834 |
| 成立以来 | 202.30% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.87% 205/1070 |
-2.75% 751/1101 |
- - |
- - |
| 2025 | 63.67% 87/1065 |
4.76% 426/1014 |
0.46% 651/1038 |
52.40% 72/1050 |
2.04% 302/1065 |
| 2024 | 0.47% 568/1011 |
-11.93% 824/960 |
-10.61% 884/983 |
19.51% 72/991 |
6.78% 98/1011 |
| 2023 | -28.74% 796/952 |
-3.91% 768/880 |
-6.63% 618/895 |
-16.00% 798/915 |
-5.46% 557/952 |
| 2022 | -33.36% 686/867 |
-17.35% 388/773 |
12.62% 173/806 |
-22.69% 780/845 |
-7.40% 721/867 |
| 2021 | 26.72% 95/740 |
-8.83% 464/580 |
26.93% 66/659 |
8.08% 82/704 |
1.32% 382/740 |
| 2020 | 108.00% 18/554 |
0.98% 136/419 |
31.81% 101/466 |
15.84% 133/517 |
34.90% 26/554 |
| 2019 | 61.47% 72/410 |
29.59% 392/1146 |
-3.81% 633/1228 |
13.90% 55/390 |
13.72% 77/410 |
| 2018 | -27.64% 187/349 |
- - |
-15.77% 790/990 |
-8.19% 659/1000 |
-1.20% 13/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 嘉实新能源新材料股票A VS. 东吴新产业精选股票A(580008) |